BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

314 related articles for article (PubMed ID: 9182920)

  • 1. The synovial expression and serum levels of interleukin-6, interleukin-11, leukemia inhibitory factor, and oncostatin M in rheumatoid arthritis.
    Okamoto H; Yamamura M; Morita Y; Harada S; Makino H; Ota Z
    Arthritis Rheum; 1997 Jun; 40(6):1096-105. PubMed ID: 9182920
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Oncostatin M stimulates monocyte chemoattractant protein-1- and interleukin-1-induced matrix metalloproteinase-1 production by human synovial fibroblasts in vitro.
    Langdon C; Leith J; Smith F; Richards CD
    Arthritis Rheum; 1997 Dec; 40(12):2139-46. PubMed ID: 9416850
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synovial fluid levels of tumor necrosis factor alpha and oncostatin M correlate with levels of markers of the degradation of crosslinked collagen and cartilage aggrecan in rheumatoid arthritis but not in osteoarthritis.
    Manicourt DH; Poilvache P; Van Egeren A; Devogelaer JP; Lenz ME; Thonar EJ
    Arthritis Rheum; 2000 Feb; 43(2):281-8. PubMed ID: 10693867
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Regulation of pre-B cell colony-enhancing factor by STAT-3-dependent interleukin-6 trans-signaling: implications in the pathogenesis of rheumatoid arthritis.
    Nowell MA; Richards PJ; Fielding CA; Ognjanovic S; Topley N; Williams AS; Bryant-Greenwood G; Jones SA
    Arthritis Rheum; 2006 Jul; 54(7):2084-95. PubMed ID: 16802343
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Osteoblasts and stromal cells isolated from femora in rheumatoid arthritis (RA) and osteoarthritis (OA) patients express IL-11, leukaemia inhibitory factor and oncostatin M.
    Lisignoli G; Piacentini A; Toneguzzi S; Grassi F; Cocchini B; Ferruzzi A; Gualtieri G; Facchini A
    Clin Exp Immunol; 2000 Feb; 119(2):346-53. PubMed ID: 10632674
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Circulating IL-6-type cytokines and sIL-6R in patients with multiple myeloma.
    Wierzbowska A; Urbańska-Ryś H; Robak T
    Br J Haematol; 1999 May; 105(2):412-9. PubMed ID: 10233412
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of azacytidine in the release of leukemia inhibitory factor, oncostatin m, interleukin (IL)-6, and IL-11 by mononuclear cells of patients with refractory anemia.
    López-Karpovitch X; Barrales-Benítez O; Flores M; Piedras J
    Cytokine; 2002 Nov; 20(4):154-62. PubMed ID: 12543079
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Formation of autocrine loops in human cerebral meningioma tissue by leukemia inhibitor factor, interleukin-6, and oncostatin M: inhibition of meningioma cell growth in vitro by recombinant oncostatin M.
    Schrell UM; Koch HU; Marschalek R; Schrauzer T; Anders M; Adams E; Fahlbusch R
    J Neurosurg; 1998 Mar; 88(3):541-8. PubMed ID: 9488310
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interferon-gamma-inducing activity of interleukin-18 in the joint with rheumatoid arthritis.
    Yamamura M; Kawashima M; Taniai M; Yamauchi H; Tanimoto T; Kurimoto M; Morita Y; Ohmoto Y; Makino H
    Arthritis Rheum; 2001 Feb; 44(2):275-85. PubMed ID: 11229457
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The role of oncostatin M in animal and human connective tissue collagen turnover and its localization within the rheumatoid joint.
    Cawston TE; Curry VA; Summers CA; Clark IM; Riley GP; Life PF; Spaull JR; Goldring MB; Koshy PJ; Rowan AD; Shingleton WD
    Arthritis Rheum; 1998 Oct; 41(10):1760-71. PubMed ID: 9778217
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Oncostatin M acting via OSMR, augments the actions of IL-1 and TNF in synovial fibroblasts.
    Le Goff B; Singbrant S; Tonkin BA; Martin TJ; Romas E; Sims NA; Walsh NC
    Cytokine; 2014 Aug; 68(2):101-9. PubMed ID: 24767864
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Production of interleukin-7 and interleukin-15 by fibroblast-like synoviocytes from patients with rheumatoid arthritis.
    Harada S; Yamamura M; Okamoto H; Morita Y; Kawashima M; Aita T; Makino H
    Arthritis Rheum; 1999 Jul; 42(7):1508-16. PubMed ID: 10403280
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of cathepsins K and S expression within the rheumatoid and osteoarthritic synovium.
    Hou WS; Li W; Keyszer G; Weber E; Levy R; Klein MJ; Gravallese EM; Goldring SR; Brömme D
    Arthritis Rheum; 2002 Mar; 46(3):663-74. PubMed ID: 11920402
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Induction of CCL13 expression in synovial fibroblasts highlights a significant role of oncostatin M in rheumatoid arthritis.
    Hintzen C; Quaiser S; Pap T; Heinrich PC; Hermanns HM
    Arthritis Rheum; 2009 Jul; 60(7):1932-43. PubMed ID: 19565514
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serum levels of IL-6 type cytokines and soluble IL-6 receptors in active B-cell chronic lymphocytic leukemia and in cladribine induced remission.
    Robak T; Wierzbowska A; Błasińska-Morawiec M; Korycka A; Błoński JZ
    Mediators Inflamm; 1999; 8(6):277-86. PubMed ID: 10815616
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serum levels of interleukin-6 type cytokines and soluble interleukin-6 receptor in patients with rheumatoid arthritis.
    Robak T; Gladalska A; Stepień H; Robak E
    Mediators Inflamm; 1998; 7(5):347-53. PubMed ID: 9883970
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interleukin-4 but not interleukin-10 inhibits the production of leukemia inhibitory factor by rheumatoid synovium and synoviocytes.
    Dechanet J; Taupin JL; Chomarat P; Rissoan MC; Moreau JF; Banchereau J; Miossec P
    Eur J Immunol; 1994 Dec; 24(12):3222-8. PubMed ID: 7805751
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Leukemia inhibitory factor is expressed in cartilage and synovium and can contribute to the pathogenesis of arthritis.
    Lotz M; Moats T; Villiger PM
    J Clin Invest; 1992 Sep; 90(3):888-96. PubMed ID: 1522240
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Induction of leukemia inhibitory factor in human synovial fibroblasts by IL-1 and tumor necrosis factor-alpha.
    Hamilton JA; Waring PM; Filonzi EL
    J Immunol; 1993 Feb; 150(4):1496-502. PubMed ID: 8432990
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The JAK inhibitor baricitinib inhibits oncostatin M induction of proinflammatory mediators in ex-vivo synovial derived cells.
    Weston S; Macdonald JL; Williams LM; Roussou E; Kang NV; Kiriakidis S; Taylor PC
    Clin Exp Rheumatol; 2022 Sep; 40(9):1620-1628. PubMed ID: 34665696
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.